Ȩ > Publication > ±¹ Á¦

ÀÛ¼ºÀÚ :      ÀÛ¼ºÀÏ :     2009-02-26 (14:03:51)
À̸ÞÀÏ :      Á¶È¸¼ö :     51024
ȨÆäÀÌÁö :      ¾ÆÀÌÇÇ :     ***.***.***.***
±ÛÁ¦¸ñ :     Plasma type IV collagen and fibronectin concentrations in diabetic patients with microangiopathy
 
 J Korean Med Sci. 1994 Aug;9(4):341-6.

Plasma type IV collagen and fibronectin concentrations in diabetic patients with microangiopathy.

Department of Internal Medicine, School of Medicine, Keimyung University, Korea.

In diabetes mellitus, thickening of basement membrane in capillaries and small vessels is a well-known finding and important in the progression of diabetic microangiopathy. We evaluated whether the plasma levels of type IV collagen and fibronectin, which are important factors of basement membrane, are related with the presence of diabetic microangiopathy. Plasma type IV collagen and fibronectin levels were measured in 40 healthy controls (Mean +/- SD, age; 50.3 +/- 5.5 yr) and 94 diabetic patients (age; 52.4 +/- 13.5 yr) with and without microvascular complications. The mean plasma levels of type IV collagen (5.3 +/- 2.9 ng/ml) and fibronectin (474.4 +/- 119.4 ug/ml) in diabetic patients were significantly higher (p < 0.01) than in healthy controls (3.7 +/- 1.3 ng/ml and 319 +/- 50.9 ug/ml). The mean plasma level of type IV collagen in diabetic patients with complications (6.6 +/- 3.7 ng/ml) was significantly higher (p < 0.01) than in those without complications (4.3 +/- 1.7 ng/ml) and became higher in more complicated patients. Furthermore, the severity of retinopathy and several indicators of nephropathy such as serum BUN, creatinine and proteinuria were closely associated with plasma type IV collagen level and a significant correlation was found between plasma type IV collagen and creatinine clearance (r = -0.31, p < 0.001). There was no significant difference in plasma fibronectin concentrations, however, between the diabetic patients with complications and those without complications.(ABSTRACT TRUNCATED AT 250 WORDS)

PMID: 7848583 [PubMed - indexed for MEDLINE]

 
 
 
name :
password :
  comment :
 
 
ÀÌÀü±Û ¸ñ·Ï »õ±Û¾²±â ÀÀ´ä±Û¾²±â ±Û¼öÁ¤Çϱ⠱ÛÁö¿ì±â ´ÙÀ½±Û



96 Metastatic pleural cancer in radionuclide angiocardiography. A pulmonary time-activity curve mimicki  2009.02.2744356
Plasma type IV collagen and fibronectin concentrations in diabetic patients with microangiopathy  2009.02.2651024
94 Prevention of glomerular dysfunction in diabetic rats by treatment with d-alpha-tocopherol.  2009.02.2641261
93 d-Alpha-tocopherol prevents the hyperglycemia induced activation of diacylglycerol (DAG)-protein kin  2009.02.2636629
92 Transcription factor decoy for activator protein-1 (AP-1) inhibits high glucose- and angiotensin II-  2009.02.2639514
91 Effect of estrogen on endothelial dysfunction in postmenopausal women with diabetes.  2009.02.2646191
90 The effect of parental imprinting on the INS-IGF2 locus of Korean type I diabetic patients.  2009.02.2640400
89 Usefulness of lumbar AP spine DXA for measuring the percentage of perilumbar regional fat and predic  2009.02.2637997
88 Asian-specific HLA haplotypes reveal heterogeneity of the contribution of HLA-DR and -DQ haplotypes  2009.02.2644724
87 Inhibitory effects of novel AP-1 decoy oligodeoxynucleotides on vascular smooth muscle cell prolifer  2009.02.2645725
86 Endothelial dysfunction: its relationship with acute hyperglycaemia and hyperlipidemia.  2009.02.2645356
85 Novel E2F decoy oligodeoxynucleotides inhibit in vitro vascular smooth muscle cell proliferation and  2009.02.2640881
84 Statin inhibits interferon-gamma-induced expression of intercellular adhesion molecule-1 (ICAM-1) in  2009.02.2643575
83 Postprandial hypertriglyceridemia-induced endothelial dysfunction in healthy subjects is independent  2009.02.2644014
82 Selective beta-cell loss and alpha-cell expansion in patients with type 2 diabetes mellitus in Korea  2009.02.2640687
81 Oleic acid induces endothelin-1 expression through activation of protein kinase C and NF-kappa B.  2009.02.2640105
80 Modulation of Sp1-dependent transcription by a cis-acting E2F element in dhfr promoter.  2009.02.2639395
79 Dykellic acid inhibits phorbol myristate acetate-induced matrix metalloproteinase-9 expression by in  2009.02.2639423
78 Functional characterization of the human resistin promoter with adipocyte determination- and differe  2009.02.2641826
77 Betacellulin and amphiregulin induce upregulation of cyclin D1 and DNA synthesis activity through di  2009.02.2641684
 1 [2][3][4][5]
¸ñ·Ï »õ±Û¾²±â